Pharmaceutical Technology

DECEMBER 22, 2023

Discover a novel compound, donepezil ether palmitate, that reduces side effects and offers sustained release for treating dementia. Learn more here.

Side effects 40

Side effects Pharmaceutical 40

Pharmaceutical Technology

MARCH 13, 2023

The US Food and Drug Administration (FDA) has granted approval for Acadia Pharmaceuticals ’ Daybue (trofinetide) to treat Rett syndrome in adult and paediatric patients aged two years and above. Acadia Pharmaceuticals CEO Steve Davis said: “Today marks an important milestone for the Rett community and Acadia.

Food and Drug Administration 72

Food and Drug Administration Pharmaceutical FDA Side effects 72

Rep-Lite

DECEMBER 7, 2023

Getting into pharmaceutical sales and selling pharmaceutical products may require patience and persistence, but for individuals with the right qualifications and a passion for the field, it can be a rewarding and financially lucrative career. What is Pharmaceutical Sales? Why Pursue a Career in Pharmaceutical Sales?

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Interpersonal Skills 52

Pharmaceutical Technology

MARCH 9, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical 52

Pharmaceutical Leads Side effects 52

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. In the pharmaceutical industry, content marketing can be particularly effective for driving sales.

Marketing 98

Marketing Pharmaceutical Sales Education 98

Pharmaceutical Technology

FEBRUARY 13, 2024

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.

Side effects 110

Side effects Medicine 110

Contrarian Sales Techniques

FEBRUARY 26, 2023

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5%

Pharmaceutical 52

Pharmaceutical Medicine Government Side effects 52

MedCity News

NOVEMBER 21, 2022

The deal gives the pharmaceutical giant a small molecule that could provide an alternative to a class of drugs that introduce dangerous side effects. Merck is acquiring Imago BioSciences, a clinical-stage biotech whose lead drug is in development for myelofibrosis and other blood cancers.

Side effects 104

Side effects Leads Pharmaceutical Biopharma 104

Eversana Intouch

APRIL 4, 2024

MM+M recently named Teva Pharmaceuticals’ AUSTEDO XR campaign as their Campaign of the Week! AUSTEDO XR helps treat tardive dyskinesia (TD), a side effect of taking medications for mental illness. It’s estimated that some 85% of TD cases go undiagnosed.

Side effects 77

Side effects Healthcare Provider Healthcare Healthcare 77

Pharmaceutical Technology

MARCH 26, 2024

Learn how this method can reduce chemotherapy side effects and improve patient outcomes. Discover GlycoMimetics Inc.'s s groundbreaking patent for treating cancer and related conditions with Formula (I) compound.

Side effects 59

Side effects Patients 59

Pharmaceutical Technology

APRIL 24, 2024

Learn about the innovative method to activate nerves without side effects. Discover a groundbreaking patent by Viatris Inc for treating dry eye disease with varenicline nasal spray.

Side effects 52

Side effects 52

Contrarian Sales Techniques

JANUARY 25, 2023

When I first started working as a pharmaceutical sales representative, I didn't fully understand the importance of product knowledge and accurate information. As a pharmaceutical sales representative, I have received extensive training on the products I represent.

Product Knowledge 52

Product Knowledge Pharmaceutical Sales Sales Pharmaceutical 52

Contrarian Sales Techniques

JUNE 18, 2023

Pharmaceutical sales comprise a dynamic, demanding, and rewarding field. Within it, knowing how to effectively finalize a sale is an invaluable ability that plays a pivotal role in successful pharmaceutical selling techniques. This situation underlines the evolving nature of the pharmaceutical sales field.

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Pharmaceutical Doctors 52

Pharmaceutical Technology

MAY 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical 52

Pharmaceutical Leads Side effects Medicine 52

Pharmaceutical Technology

JANUARY 6, 2023

While the treatment options for multiple sclerosis (MS) patients are growing each year with the approval of new agents, all of the currently marketed treatments only slow the disease’s progression and sometimes carry risks of severe side effects, such as liver failure or the development of viral infections.

Side effects 115

Side effects Patients Marketing Safety 115

Pharma Marketing Network

MAY 3, 2023

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

European Pharmaceutical Review

OCTOBER 9, 2023

This helps “to avoid dramatic spikes that worsen side effects, and dips that allow seizures to return. Among the results, the study revealed no signs of serious side effects such as heart problems, allergic reactions, or concerning skin discolorations.

Side effects 98

Side effects Recruitment Safety Medicine 98

Pharmaceutical Technology

NOVEMBER 9, 2022

This comprises wide-ranging data on the safety and effectiveness of the initial vaccine, clinical findings from the bivalent original/omicron BA.1 According to these data, the common side effects reported with the new bivalent vaccine were similar to those observed for other vaccine versions.

Side effects 105

Side effects Safety Medicine Healthcare 105

European Pharmaceutical Review

APRIL 5, 2024

These interim data indicate early signs of potential clinical benefit with mRNA-3927, and importantly also demonstrate that mRNA-3927 has infrequent treatment-limiting side effects. The post mRNA therapy could provide intracellular protein replacement for rare disease appeared first on European Pharmaceutical Review.

Side effects 92

Side effects Safety Patients Leads 92

European Pharmaceutical Review

OCTOBER 31, 2022

The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects. Risks of amfepramones.

Side effects 86

Side effects Medicine Safety Marketing 86

European Pharmaceutical Review

MARCH 25, 2024

The most common side effects in patients treated with Emblaveo were a decrease in the number of red blood cells, elevated levels of liver transaminase and diarrhoea. The post Positive CHMP recommendation for antibiotic combination appeared first on European Pharmaceutical Review. Emblaveo was jointly developed with AbbVie.

Side effects 95

Side effects Medicine Safety Patients 95

Pharmaceutical Technology

JANUARY 12, 2024

The UK nod for Agamree, which comes after previous approvals in Europe and the US, provides access to a corticosteroid with less severe side effects.

Side effects 52

Side effects Patients 52

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 91

Side effects Distribution Safety Patients 91

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

European Pharmaceutical Review

NOVEMBER 24, 2023

Interestingly, compared to the 10mg dose, a 100mg dose was also evaluated in patients, but was found to be less effective and have lower benefit in terms of side effects. The post New Amgen immunotherapy could treat common solid tumour appeared first on European Pharmaceutical Review.

Side effects 109

Side effects Patients Medicine Leads 109

European Pharmaceutical Review

MARCH 9, 2023

This is very exciting because not only does our study suggest that this new monoclonal antibody drug is safe and can modulate the immune system without major side effects,” Moreira added. Findings revealed a pattern of three specific genes (NKG7, TGF beB1, and GIMAP7) involved with the anti-inflammatory effects of the drug.

Side effects 145

Side effects Patients Leads Medical 145

European Pharmaceutical Review

MARCH 14, 2024

Sosei Heptares’ treatment aims to address the significant population of schizophrenia patients who are unresponsive to existing treatments or who cannot tolerate some of the side effects of antipsychotics, Boehringer Ingelheim noted.

Side effects 80

Side effects Sales Pharmaceutical Patients 80

European Pharmaceutical Review

MARCH 8, 2023

The study found no evidence of serious side effects and no evidence that side effects increased with higher doses of MK-0616. The post Oral PCSK9 inhibitor substantially reduces cholesterol, study finds appeared first on European Pharmaceutical Review. Plans for a Phase III clinical trial programme are underway.

Side effects 90

Side effects Safety Medicine Patients 90

Silver Line CRM

NOVEMBER 11, 2020

Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? Pharmaceutical, biotech, and life sciences companies bring life-changing medicines to a highly regulated market. 2021 pharmaceutical industry trends — and how you can implement them.

Marketing 52

Marketing Pharmaceutical Side effects Insurance 52

European Pharmaceutical Review

APRIL 20, 2023

“These results are exciting… this treatment led to fewer days with migraine for people who had already tried up to four other types of drugs to prevent migraine and either had no improvement or had side effects that outweighed any benefits,” commented study author Dr Patricia Pozo-Rosich, PhD at Vall d’Hebron University Hospital in Barcelona, Spain.

Side effects 90

Side effects Safety Medical Pharmaceutical 90

Pharmaceutical Representative Training

FEBRUARY 29, 2024

Embark on a journey to success in pharmaceutical sales with our comprehensive guide tailored for aspiring representatives. Unveiling the Role of a Pharma Sales Rep Pharmaceutical sales representatives (PSRs) play a pivotal role in driving sales for their company’s pharmaceutical products. Their mission?

Sales 52

Sales Pharma Pharmaceutical Sales Pharma sales reps 52

European Pharmaceutical Review

DECEMBER 22, 2023

It has demonstrated improvements in cognition and is not associated with common side effects of currently approved treatments like weight gain. The post BMS strikes $14bn deal for Karuna Therapeutics appeared first on European Pharmaceutical Review.

Food and Drug Administration 96

Food and Drug Administration Side effects Safety Food 96

European Pharmaceutical Review

NOVEMBER 2, 2023

This evidence included comparisons of the products on an analytical level using chemical and biological tests and assays that confirmed similarity in the structural and functional features of Wezlana and Stelara, as well as comparative human pharmacokinetic data, clinical immunogenicity data and other clinical safety and effectiveness data.

Food and Drug Administration 92

Food and Drug Administration FDA Side effects Safety 92

European Pharmaceutical Review

NOVEMBER 22, 2022

. “Delaying drug release and delivering oral dosage forms to the colon is challenging, so T21 offers a promising new option for ulcerative colitis patients by providing site-specific drug delivery and localised drug effect, mitigating potential side effects from systemic exposure.

Food and Drug Administration 107

Food and Drug Administration Side effects FDA Medicine 107

European Pharmaceutical Review

NOVEMBER 1, 2023

The most common side effects with Nuvaxovid XBB.1.5 The post European approval for third adapted COVID-19 vaccine appeared first on European Pharmaceutical Review. Based on these data, the Committee concluded that Nuvaxovid XBB.1.5 is expected to trigger an adequate immune response against XBB.1.5. The Comirnaty XBB.1.5-adapted

Side effects 101

Side effects Medicine Safety Marketing 101

European Pharmaceutical Review

NOVEMBER 16, 2023

According to Vertex Pharmaceuticals and CRISPR Therapeutics, Casgevy is a genetically modified autologous CD34+ cell enriched population containing human hematopoietic stem and progenitor cells edited ex vivo by CRISPR/Cas9 at the erythroid-specific enhancer region of the BCL11A gene.

Safety 98

Safety Side effects Medicine Patients 98

European Pharmaceutical Review

NOVEMBER 18, 2022

The most common side effects observed were initial insomnia, irritability and dyskinesia. The post MHRA approves first gene therapy for infusion into the brain appeared first on European Pharmaceutical Review. Significant improvements were shown to continue up to ten years post-treatment.

Side effects 126

Side effects Biopharma Safety Patients 126